Background: Novel coronavirus infectious disease (COVID-19) has been spreading worldwide, and tracking laboratory indexes during the diagnosis and treatment of patients with severe COVID-19 can provide a reference for patients in other countries and regions.
Methods: We closely tracked the epidemiological history, diagnosis and treatment process, as well as dynamic changes in routine blood indicators, of a severe COVID-19 patient who was hospitalized for 26 days.
Results: Our study found that the patient's condition worsened in the first week after admission, white blood cells (WBCs), neutrophils, lymphocytes, monocytes, eosinophils, red blood cells (RBCs), hemoglobin, neutrophil lymphocyte ratio (NLR), platelets (PLT) and platelet lymphocyte ratio (PLR) decreased. On the 7th day of admission, the levels of these cells decreased to their lowest values, though the red blood cell distribution width (RDW) and C-reactive protein (CRP) level remained at high values. From 8 to 14 days of admission, the patient's condition improved, hypoxemia was corrected, and mechanical ventilation was discontinued. The number of WBCs, neutrophils, monocytes, eosinophils and lymphocytes increased gradually, and the erythrocyte parameters stopped declining and stabilized in a certain range; CRP decreased rapidly. On the 20th day of admission, the nucleic acid test was negative, WBC, neutrophil, CRP, NLR and PLR decreased gradually, and monocyte, lymphocyte, and eosinophil counts increased. Although RBCs and hemoglobin (Hb) levels continued to decrease, RDW gradually increased, indicating the recovery of hematopoiesis. In addition, it should be noted that monocytes and eosinophils were at extremely low levels within 10 days after admission; the recovery time of eosinophils was approximately 12 days after admission, which was earlier than other parameters, which might be of great value in judging the progress of the disease.
Conclusions: Dynamic changes in routine blood parameters might be helpful for the prognosis of COVID-19 patients and evaluation of the treatment effect.
Keywords: COVID-19; Dynamic; Routine blood parameters.
Copyright © 2020 Elsevier B.V. All rights reserved.
Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China.Clin Chim Acta. 2020 Aug;507:174-180. doi: 10.1016/j.cca.2020.04.024. Epub 2020 Apr 24. Clin Chim Acta. 2020. PMID: 32339487 Free PMC article.
Diagnostic value of blood parameters for community-acquired pneumonia.Int Immunopharmacol. 2018 Nov;64:10-15. doi: 10.1016/j.intimp.2018.08.022. Epub 2018 Aug 23. Int Immunopharmacol. 2018. PMID: 30144639
Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds.Eur Arch Otorhinolaryngol. 2016 Nov;273(11):3663-3672. doi: 10.1007/s00405-016-3980-y. Epub 2016 Mar 31. Eur Arch Otorhinolaryngol. 2016. PMID: 27034281 Clinical Trial.
[Dynamic monitoring of the neutrophil/lymphocyte ratio could predict the prognosis of patients with bloodstream infection].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Jun;27(6):471-6. doi: 10.3760/cma.j.issn.2095-4352.2015.06.011. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015. PMID: 26049186 Chinese.
Relationship between monocytes to lymphocytes ratio and axial spondyloarthritis.Int Immunopharmacol. 2018 Apr;57:43-46. doi: 10.1016/j.intimp.2018.02.008. Epub 2018 Feb 22. Int Immunopharmacol. 2018. PMID: 29471252
- Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., Si H.R., Zhu Y., Li B., Huang C.L., Chen H.D., Chen J., Luo Y., Guo H., Jiang R.D., Liu M.Q., Chen Y., Shen X.R., Wang X., Zheng X.S., Zhao K., Chen Q.J., Deng F., Liu L.L., Yan B., Zhan F.X., Wang Y.Y., Xiao G.F., Shi Z.L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020
- Lu R., Zhao X., Li J. Genomic characterization and epidemiology of *019 novel coronavirus: implications of virus origins and receptor binding. Lancet. 2020
- Yang M., Li C.K., Li K., Hon K.L., Ng M.H., Chan P.K., Fok T.F. Hematological findings in SARS patients and possible mechanisms (review) Int. J. Mol. Med. 2004;14(2):311–315. - PubMed
- Terpos E., Ntanasis-Stathopoulos I., Elalamy I., Kastritis E., Sergentanis T.N., Politou M., Psaltopoulou T., Gerotziafas G., Dimopoulos M.A. Hematological findings and complications of COVID-19. Am. J. Hematol. 2020